3-Nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions

Journal of Neuroscience Research

Volumn 88, Issue 3, 2010, Pages 630-639

  Mirandola, Sandra R ^a   Melo, Daniela R ^a   Saito, Ângela ^a   Castilho, Roger F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Apoptosis; Brain mitochondria; Calcium; Huntington's disease; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; ADENOSINE DIPHOSPHATE; CALCIUM ION; GLUTAMATE RECEPTOR; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; BREATHING; CALCIUM TRANSPORT; CELL ORGANELLE; CEREBELLUM; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CORPUS STRIATUM; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; FOREBRAIN; GENETIC SUSCEPTIBILITY; HEART; KIDNEY PARENCHYMA; LIVER; MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOCHONDRION SWELLING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE HOMOGENATE;

ANIMALS; BRAIN; CALCIUM; CELL MEMBRANE PERMEABILITY; CEREBELLUM; CEREBRAL CORTEX; CORPUS STRIATUM; ENZYME INHIBITORS; FEMALE; KIDNEY; MITOCHONDRIA; MITOCHONDRIA, HEART; MITOCHONDRIA, LIVER; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINATE DEHYDROGENASE;

EID: 73949159907     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22239     Document Type: Article

References (66)

1. Åkerman KE, Wikström MK. 1976. Safranine as a probe of the mitochondrial membrane potential. FEBS Lett 68:191-197.
2. Albin RL, Greenamyre JT. 1992. Alternative excitotoxic hypotheses. Neurology 42:733-738.
3. Almeida S, Domingues A, Rodrigues L, Oliveira CR, Rego AC. 2004. FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol Dis 17:435-444.
4. Andreyev AY, Fahy B, Fiskum G. 1998. Cytochrome c release from brain mitochondria is independent of the mitochondrial permeability transition. FEBS Lett 439:373-376.
5. Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P. 1996. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett 394:321-324.
6. Beal MF. 2001. Experimental models of Parkinson's disease. Nat Rev Neurosci 2:325-334.
7. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192.
8. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N, Delage JP, Casteilla L, Letellier T, Rossignol R. 2006. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 291:C1172-C1182.
9. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
10. Bizat N, Hermel JM, Boyer F, Jacquard C, Créminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E. 2003. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J Neurosci 23:5020-5030.
11. Borlongan CV, Koutouzis TK, Sanberg PR. 1997. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 21:289-293.
12. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Péquignot E, Munnich A, Rö tig A. 1995. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144-149.
13. Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. 1993. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60:356-359.
14. Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P. 1998. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805.
15. Brouillet E, Jacquard C, Bizat N, Blum D. 2005. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95:1521-1540.
16. Brustovetsky N, Brustovetsky T, Purl KJ, Capano M, Crompton M, Dubinsky JM. 2003. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci 23:4858-4867.
17. 2+: effect of coenzyme Q redox state. Free Radic Biol Med 18:55-59.
18. Castilho RF, Hansson O, Ward MW, Budd SL, Nicholls DG. 1998. Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 18:10277-10286.
19. Castilho RF, Hansson O, Brundin P. 2000. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons. Exp Neurol 164:94-101.
20. Cepeda C, Levine MS. 1998. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci 20:1-18.
21. Chen YR, Chen CL, Pfeiffer DR, Zweier JL. 2007. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem 282:32640-32654.
22. Cooper JM, Schapira AH. 1997. Mitochondrial dysfunction in neurodegeneration. J Bioenerg Biomembr 29:175-183.
23. Crompton M. 1999. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233-249.
24. Fabiato A, Fabiato F. 1978. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 276:233-255.
25. Fiskum G, Murphy AN, Beal MF. 1999. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab 19:351-369.
26. FitzPatrick DR, Hill A, Tolmie JL, Thorburn DR, Christodoulou J. 1999. The molecular basis of malonyl-CoA decarboxylase deficiency. Am J Hum Genet 65:318-326.
27. Fontaine E, Ichas F, Bernardi P. 1998. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273:25734-25740.
28. Friberg H, Wieloch T. 2002. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84:241-250.
29. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. 1998. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 18:5151-5159.
30. Gabrielson KL, Hogue BA, Bohr VA, Cardounel AJ, Nakajima W, Kofler J, Zweier JL, Rodriguez ER, Martin LJ, de Souza-Pinto NC, Bressler J. 2001. Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. Am J Pathol 159:1507-1520.
31. Garcia M, Vanhoutte P, Pages C, Besson MJ, Brouillet E, Caboche J. 2002. The mitochondrial toxin 3-nitropropionic acid induces striata neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J Neurosci 22:2174-2184.
32. Greene JG, Sheu SS, Gross RA, Greenamyre JT. 1998. 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84:503-510.
33. Hamilton BF, Gould DH. 1987. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 72:286-297.
34. Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, Wieloch T, Elmér E. 2003. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 960:99-111.
35. He K, Ludtke SJ, Worcester DL, Huang HW. 1996. Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J 70:2659-2666.
36. Horváth R, Abicht A, Holinski-Feder E, Laner A, Gempel K, Prokisch H, Lochmü ller H, Klopstock T, Jaksch M. 2006. Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77:74-76.
37. Jakel RJ, Maragos WF. 2000. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci 23:239-245.
38. Jarmuszkiewicz W, Navet R, Alberici LC, Douette P, Sluse-Goffart CM, Sluse FE, Vercesi AE. 2004. Redox state of endogenous coenzyme q modulates the inhibition of linoleic acid-induced uncoupling by guanosine triphosphate in isolated skeletal muscle mitochondria. J Bioenerg Biomembr 36:493-502.
39. Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP. 1998. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 18:4439-4450.
40. Kim JS, He L, Lemasters JJ. 2003. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463-470.
41. 2 generation is decreased by calcium in isolated brain mitochondria. Biochim Biophys Acta 1777:800-807.
42. Kowaltowski AJ, Castilho RF, Vercesi AE. 2001. Mitochondrial permeability transition and oxidative stress. FEBS Lett 495:12-15.
43. Kowaltowski AJ, Maciel EN, Fornazari M, Castilho RF. 2006. Diazoxide protects against methylmalonate-induced neuronal toxicity. Exp Neurol 201:165-171.
44. Leventhal L, Sortwell CE, Hanbury R, Collier TJ, Kordower JH, Palfi S. 2000. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J Comp Neurol 425:471-478.
45. Lin MT, Beal MF. 2006. Alzheimer's APP mangles mitochondria. Nat Med 12:1241-1243.
46. Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E. 2009. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899-909.
47. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M. 1991. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492-498.
48. 2+ and respiratory chain complex II inhibition. J Neurochem 90:1025-1035.
49. Mirandola SR, Melo DR, Schuck PF, Ferreira GC, Wajner M, Castilho RF. 2008. Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31:44-54.
50. Murphy AN, Fiskum G, Beal MF. 1999. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 19:231-245.
51. Nicholls DG, Budd SL. 2000. Mitochondria and neuronal survival. Physiol Rev 80:315-360.
52. Nishimura M, Okimura Y, Fujita H, Yano H, Lee J, Suzaki E, Inoue M, Utsumi K, Sasaki J. 2008. Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by L-carnitine. Cell Biochem Funct 26:881-891.
53. Nishino H, Hida H, Kumazaki M, Shimano Y, Nakajima K, Shimizu H, Ooiwa T, Baba H. 2000. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 17:251-260.
54. Okun JG, Hö rster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S. 2002. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674-14680.
55. Orth M, Schapira AH. 2001. Mitochondria and degenerative disorders. Am J Med Genet 106:27-36.
56. Rosenstock TR, Carvalho AC, Jurkiewicz A, Frussa-Filho R, Smaili SS. 2004. Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88:1220-1228.
57. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. 1987. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 7:752-758.
58. Rossignol R, Malgat M, Mazat JP, Letellier T. 1999. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem 274:33426-33432.
59. Ruan Q, Lesort M, MacDonald ME, Johnson GV. 2004. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Hum Mol Genet 13:669-681.
60. Salomons GS, Jakobs C, Pope LL, Errami A, Potter M, Nowaczyk M, Olpin S, Manning N, Raiman JA, Slade T, Champion MP, Peck D, Gavrilov D, Hillman R, Hoganson GE, Donaldson K, Shield JP, Ketteridge D, Wasserstein M, Gibson KM. 2007. Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency. J Inherit Metab Dis 30:23-28.
61. Schon EA, Manfredi G. 2003. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303-312.
62. Schulz JB, Henshaw DR, MacGarvey U, Beal MF. 1996. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int 29:167-171.
63. Shepherd JA, Garland PB. 1969. Citrate synthase from rat liver. Methods Enzymol 13:11-19.
64. Singer TP. 1974. Determination of the activity of succinate, NADH, choline, and alpha-glycerophosphate dehydrogenases. Methods Biochem Anal 22:123-175.
65. 2+ transport, permeability transition and oxidative stress in cell death: implications in cardiotoxicity, neurodegeneration and dyslipidemias. Front Biosci 11:2554-2564.
66. 2+ loads by mitochondria in cultured rat hippocampal neurons. J Neurophysiol 76:1611-1621.